These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26292865)

  • 1. Re: Urgency after a Sling: Review of the Management.
    Wein AJ
    J Urol; 2015 Sep; 194(3):728-9. PubMed ID: 26292865
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Urgency after a sling: review of the management.
    Wein AJ
    J Urol; 2015 Feb; 193(2):608. PubMed ID: 25617284
    [No Abstract]   [Full Text] [Related]  

  • 3. Urgency after a sling: review of the management.
    Abraham N; Vasavada S
    Curr Urol Rep; 2014 Apr; 15(4):400. PubMed ID: 24515329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New treatments for incontinence.
    MacLachlan LS; Rovner ES
    Adv Chronic Kidney Dis; 2015 Jul; 22(4):279-88. PubMed ID: 26088072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and treatment of female urinary incontinence.
    Gamble T; Sand PK
    Minerva Urol Nefrol; 2007 Dec; 59(4):431-50. PubMed ID: 17947961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding clinic options for overactive bladder.
    Bartley JM; Blum ES; Sirls LT; Peters KM
    Curr Urol Rep; 2013 Dec; 14(6):541-8. PubMed ID: 23812967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Longitudinal Fluctuations in Treatment Response After OnabotulinumToxinA and Sacral Neuromodulation for Refractory Urgency Incontinence.
    Smits MAC; Heesakkers JPFA
    Eur Urol; 2024 Jun; 85(6):590-591. PubMed ID: 38461141
    [No Abstract]   [Full Text] [Related]  

  • 8. [Not Available].
    Bywater M; Kessler TM
    Praxis (Bern 1994); 2017; 106(21):1175-1181. PubMed ID: 29041854
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Pathophysiology of Idiopathic Overactive Bladder and the Success of Treatment: A Systematic Review from ICI-RS 2013.
    Wein AJ
    J Urol; 2015 Aug; 194(2):474. PubMed ID: 26195388
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview of treatment of overactive bladder syndrome in women.
    Allahdin S; Oo N
    J Obstet Gynaecol; 2012 Apr; 32(3):217-21. PubMed ID: 22369391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OnabotulinumtoxinA Injections for Urge Incontinence.
    Hubb AJ; Stachowicz AM; Wood SC
    Am Fam Physician; 2018 Feb; 97(3):Online. PubMed ID: 29431973
    [No Abstract]   [Full Text] [Related]  

  • 12. Contemporary management of postprostatectomy incontinence.
    Bauer RM; Gozzi C; Hübner W; Nitti VW; Novara G; Peterson A; Sandhu JS; Stief CG
    Eur Urol; 2011 Jun; 59(6):985-96. PubMed ID: 21458914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing treatments for overactive bladder.
    Waine E; Stott M
    Nurs Times; 2008 Oct 14-20; 104(41):45-8. PubMed ID: 18979960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological approach to overactive bladder and urge urinary incontinence in women: an overview.
    Cipullo LM; Cosimato C; Filippelli A; Conti V; Izzo V; Zullo F; Guida M
    Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():27-34. PubMed ID: 24411952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overactive bladder syndrome - management and treatment options.
    Arnold J; McLeod N; Thani-Gasalam R; Rashid P
    Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actual treatment of overactive bladder and urge urinary incontinence.
    Cornu JN
    Minerva Urol Nefrol; 2013 Mar; 65(1):21-35. PubMed ID: 23538308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Perucchini D; Betschart C; Fink D; Scheiner DA
    Praxis (Bern 1994); 2017 Jan; 106(1):37-44. PubMed ID: 28055318
    [No Abstract]   [Full Text] [Related]  

  • 18. Stress urinary incontinence and overactive bladder syndrome: current options and new targets for management.
    Elser DM
    Postgrad Med; 2012 May; 124(3):42-9. PubMed ID: 22691898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply from author re: Stephan Madersbacher. OnabotulinumtoxinA for idiopathic overactive bladder symptoms: many answers but more questions. Eur Urol 2013;64:257-9: OnabotulinumtoxinA for idiopathic overactive bladder symptoms: some answers but even more questions.
    Chapple CR
    Eur Urol; 2013 Nov; 64(5):e100-1. PubMed ID: 23830474
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug therapy of female urinary incontinence].
    Hampel C; Gillitzer R; Pahernik S; Melchior SW; Thüroff JW
    Urologe A; 2005 Mar; 44(3):244-55. PubMed ID: 15711814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.